109
Views
0
CrossRef citations to date
0
Altmetric
CASE REPORT

Gastrointestinal Mucormycosis-Induced Massive Lower Gastrointestinal Bleeding, Rectal Perforation, and Pulmonary Embolism: A Long Diagnostic Pathway in a Case Report

ORCID Icon, ORCID Icon, , , , , & show all
Pages 145-151 | Received 18 May 2022, Accepted 09 Aug 2022, Published online: 12 Aug 2022

References

  • Wotiye AB, Ks P, Ayele BA. Invasive intestinal mucormycosis in a 40-year old immunocompetent patient - a rarely reported clinical phenomenon: a case report. BMC Gastroenterol. 2020;20(1):61. doi:10.1186/s12876-020-01202-5
  • Huang H, Xie L, Zheng Z, et al. Mucormycosis-induced upper gastrointestinal ulcer perforation in immunocompetent patients: a report of two cases. BMC Gastroenterol. 2021;21:311. doi:10.1186/s12876-021-01881-8
  • Martinello M, Nelson A, Bignold L, Shaw D. “We are what we eat!” Invasive intestinal Mucormycosis: a case report and review of the literature. Med Mycol Case Rep. 2012;1:52–55. doi:10.1016/j.mmcr.2012.07.003
  • Bhat V, Thomas SA, Kanavi JV, Thomas A. Intestinal perforation secondary to mucormycosis associated with puerperal sepsis. Cureus. 2014;13(8):e17428. doi:10.7759/cureus.17428.
  • Zilberberg MD, Shorr AF, Huang H, Chaudhari P, Paly VF, Menzin J. Hospital days, hospitalization costs, and inpatient mortality among patients with mucormycosis: a retrospective analysis of US hospital discharge data. BMC Infect Dis. 2014;14(1):310. doi:10.1186/1471-2334-14-310
  • Chiang TH, Lee YW, Tan JH, Kao CC, Chang CC, Fang KC. Mucormycosis causing massive lower gastrointestinal bleeding: a case report. BMC Gastroenterol. 2021;21(1):272. doi:10.1186/s12876-021-01846-x
  • Bala K, Chander J, Handa U, Punia RS, Attri AK. A prospective study of mucormycosis in north India: experience from a tertiary care hospital. Med Mycol. 2015;53(3):248‑57. doi:10.1093/mmy/myu086
  • Lacarrière E, Lacaze L, Schwarz L, Huet E, Lemoine F, Scotté M. First case of gastrointestinal mucormycosis in an immunocompromised patient with gallbladder and duodenum involvement. Infection. 2011;39(6):595‑8. doi:10.1007/s15010-011-0165-x
  • Bitar D, Lortholary O, Dromer F, Coignard B, Che D. Mycoses invasives en France métropolitaine, PMSI 2001 2010: incidence, létalité et tendances. Bulletin Épidémiologie Hebdomadaire. 2013;12-13:109–114.
  • Bitar D, Cauteren DV, Lanternier F, et al. Increasing Incidence of zygomycosis (mucormycosis), France, 1997–2006. Emerg Infect Dis. 2009;15(9):1395–1401. doi:10.3201/eid1509.090334
  • Roden MM, Zaoutis TE, Buchanan WL, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005;41(5):634‑53.
  • Petrikkos G, Skiada A, Lortholary O, Roilides E, Walsh TJ, Kontoyiannis DP. Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis. 2012;54(suppl_1):S23–34. doi:10.1093/cid/cir866
  • Prakash H, Ghosh AK, Rudramurthy SM, et al. A prospective multicenter study on mucormycosis in India: epidemiology, diagnosis, and treatment. Med Mycol. 2019;57(4):395‑402. doi:10.1093/mmy/myy060
  • Patel AK, Patel KK, Patel K, Gohel S, Chakrabarti A. Mucormycosis at a tertiary care centre in Gujarat, India. Mycoses. 2017;60(6):407‑11. doi:10.1111/myc.12610
  • Termos S, Othman F, Alali M, et al. Total gastric necrosis due to mucormycosis: a rare case of gastric perforation. Am J Case Rep. 2018;19:527‑33. doi:10.12659/AJCR.908952
  • Song Y, Qiao J, Giovanni G, et al. Mucormycosis in renal transplant recipients: review of 174 reported cases. BMC Infect Dis. 2017;17(1):283. doi:10.1186/s12879-017-2381-1
  • Almyroudis NG, Sutton DA, Linden P, et al. Zygomycosis in solid organ transplant recipients in a tertiary transplant center and review of the literature. Am J Transplant. 2006;6:2365–2374. doi:10.1111/j.1600-6143.2006.01496.x
  • Cornely OA, Alastruey-Izquierdo A, Arenz D, et al. Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium. Lancet Infect Dis. 2019;19(12):e405‑21. doi:10.1016/S1473-3099(19)30312-3
  • Verweij PE, González GM, Wiedrhold NP, et al. In vitro antifungal activity of isavuconazole against 345 Mucorales isolates collected at study centers in eight countries. J Chemother. 2009;21(3):272–281. doi:10.1179/joc.2009.21.3.272
  • Marty FM, Perfect JR, Cornely OA, et al. An open-label phase 3 study of isavuconazole (VITAL): focus on mucormycosis [Abstract]; 2014. Available from: https://idsa.confex.com/idsa/2014/webprogram/Paper45645.html. Accessed Jun 29, 2022..